Radicava (edaravone)

Radicava (brand name) or edaravone is a prescription medicine that was recently approved for the treatment of ALS by the FDA on May 5th, 2017. Radicava is the first ALS treatment to be approved in the United States in more than 20 years.

For helpful information about the drug, when it will be available, safety concerns, financial information, etc., please click on one of the links below: